Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
MYCN proto-oncogene, bHLH transcription factor | 0.454 | 0.808 | 0.89 |
|
disease | 0.300 | limited | 0 | 0 | |||||||||||
|
protein tyrosine phosphatase non-receptor type 11 | 0.385 | 0.923 | 1.00 |
|
disease | 0.300 | moderate | 0 | 0 | |||||||||||
|
tRNA | 0.729 | 0.538 |
|
disease | 0.020 | None | < 0.001 | 2 | 0 | 1996 | 1996 | |||||||||
|
microRNA 675 | 0.595 | 0.654 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2019 | 2019 | |||||||||
|
MICOS10-NBL1 readthrough | 0.691 | 0.462 | 2.9E-02 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2019 | 2019 | ||||||||
|
RNA binding motif protein 45 | 0.383 | 0.846 | 2.1E-10 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2019 | 2019 | ||||||||
|
dopamine receptor D3 | 0.529 | 0.692 | 2.4E-03 |
|
disease | 0.010 | None | < 0.001 | 1 | 1 | 2004 | 2004 | ||||||||
|
jagged canonical Notch ligand 1 | 0.429 | 0.808 | 1.00 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2011 | 2011 | ||||||||
|
EPH receptor A1 | 0.544 | 0.731 | 1.5E-23 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2017 | 2017 | ||||||||
|
glypican 5 | 0.626 | 0.654 | 4.0E-10 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2019 | 2019 | ||||||||
|
muscle RAS oncogene homolog | 0.590 | 0.731 | 0.92 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2012 | 2012 | ||||||||
|
nuclear receptor subfamily 5 group A member 1 | 0.479 | 0.731 | 0.99 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2008 | 2008 | ||||||||
|
sclerostin domain containing 1 | 0.588 | 0.808 | 0.16 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2019 | 2019 | ||||||||
|
RRAD and GEM like GTPase 1 | 0.531 | 0.885 | 5.3E-08 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2013 | 2013 | ||||||||
|
alpha-L-iduronidase | 0.499 | 0.846 | 3.8E-13 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2011 | 2011 | ||||||||
|
integrin subunit beta 3 | 0.485 | 0.846 | 1.7E-03 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2001 | 2001 | ||||||||
|
lysosomal associated membrane protein 2 | 0.552 | 0.731 | 0.27 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2019 | 2019 | ||||||||
|
NBL1, DAN family BMP antagonist | 0.670 | 0.500 | 5.9E-02 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2019 | 2019 | ||||||||
|
necdin, MAGE family member | 0.578 | 0.654 | 0.67 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2012 | 2012 | ||||||||
|
oxidized low density lipoprotein receptor 1 | 0.544 | 0.769 | 7.2E-03 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2018 | 2018 | ||||||||
|
poly(A)-specific ribonuclease | 0.575 | 0.769 | 3.7E-04 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2019 | 2019 | ||||||||
|
sclerostin | 0.474 | 0.808 | 0.87 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2019 | 2019 | ||||||||
|
acyl-CoA oxidase 1 | 0.610 | 0.731 | 6.2E-02 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2018 | 2018 | ||||||||
|
pyruvate dehydrogenase kinase 1 | 0.510 | 0.808 | 1.1E-05 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2017 | 2017 | ||||||||
|
kirre like nephrin family adhesion molecule 1 | 0.760 | 0.346 | 1.00 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2008 | 2008 |